Literature DB >> 10224879

[Evaluation of psychometric properties of the Spanish version of the Rotterdam Symptom Checklist to assess quality of life of cancer patients].

Y Agra1, X Badía.   

Abstract

BACKGROUND: In this work the validation of the Spanish version of the Rotterdam Symptom Checklist (RSCL) to assess quality of life in cancer patients has been approached. The main goal of this study is to evaluate the psychometric properties of the questionnaire and its equivalence with the original English questionnaire.
METHODS: The questionnaire was administered to a sample of 162 terminal cancer patients and 59 cancer patients treated with chemotherapy. The internal structure, was evaluated through a confirmatory factor analysis in TCP, the discriminatory power according to clinical situation of cancer patients, the internal consistency in both samples and the responsiveness to the changes over time after chemotherapy treatment was evaluated in PQT.
RESULTS: The internal structure of scales was similar in TCP to the original version. The cancer patients showed worse scores than the PQT. The reliability was > or = 0.70 for the scales and > or = 0.50 for the subscales except chemotherapy subscale. The scores of the scales were different (p < 0.05) before and after treatment, except for the psychological scale.
CONCLUSIONS: These results confirm the usefulness of the spanish version of the RSCL as a subjective measure of well-being in cancer patients.

Entities:  

Mesh:

Year:  1999        PMID: 10224879

Source DB:  PubMed          Journal:  Rev Esp Salud Publica        ISSN: 1135-5727


  5 in total

1.  Reliability and concurrent validity of the Palliative Outcome Scale, the Rotterdam Symptom Checklist, and the Brief Pain Inventory.

Authors:  Marta Pelayo-Alvarez; Santiago Perez-Hoyos; Yolanda Agra-Varela
Journal:  J Palliat Med       Date:  2013-06-28       Impact factor: 2.947

2.  Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors.

Authors:  Margaret F Bevans; Sandra A Mitchell; John A Barrett; Michael R Bishop; Richard Childs; Daniel Fowler; Michael Krumlauf; Patricia Prince; Nonniekaye Shelburne; Leslie Wehrlen; Li Yang
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-17       Impact factor: 5.742

3.  Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Authors:  Robert Quan Le; Margaret Bevans; Bipin N Savani; Sandra A Mitchell; Kate Stringaris; Eleftheria Koklanaris; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-17       Impact factor: 5.742

4.  Clinical effectiveness of online training in palliative care of primary care physicians.

Authors:  Marta Pelayo-Alvarez; Santiago Perez-Hoyos; Yolanda Agra-Varela
Journal:  J Palliat Med       Date:  2013-08-29       Impact factor: 2.947

5.  Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol.

Authors:  Margaret F Bevans; Sandra A Mitchell; A John Barrett; Michael Bishop; Richard Childs; Daniel Fowler; Michael Krumlauf; Patricia Prince; Nonniekaye Shelburne; Leslie Wehrlen
Journal:  Health Qual Life Outcomes       Date:  2011-04-17       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.